LAVA Therapeutics NV (LVTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.74

About LAVA Therapeutics NV

LAVA Therapeutics NV is a pioneering biotechnology company dedicated to transforming cancer treatment through its innovative gamma-delta bispecific T-cell activators (gamma-delta bsTCE). Based in Utrecht, the Netherlands, LAVA boasts a promising development pipeline that utilizes its proprietary technology to create next-generation therapies aimed at effectively targeting solid tumors and hematologic malignancies. With a strong commitment to enhancing immune responses against cancer, LAVA The...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for LAVA Therapeutics NV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LVTX pay dividends?

LAVA Therapeutics NV (LVTX) does not currently pay a regular dividend.